Teemu Strengell
@tmu76.bsky.social
Geriatrician at Oulu University Hospital
Reposted by Teemu Strengell
Antidepressants vary widely in their physical side effects, highlighting the need for personalised prescribing, says major meta-analysis.
Find out more: tinyurl.com/ycxzafd4
Find out more: tinyurl.com/ycxzafd4
October 23, 2025 at 2:14 PM
Antidepressants vary widely in their physical side effects, highlighting the need for personalised prescribing, says major meta-analysis.
Find out more: tinyurl.com/ycxzafd4
Find out more: tinyurl.com/ycxzafd4
Reposted by Teemu Strengell
Discordances Between Creatinine- and Cystatin C–Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice
bit.ly/4491HQp #OpenAccess
bit.ly/4491HQp #OpenAccess
October 9, 2025 at 10:02 PM
Discordances Between Creatinine- and Cystatin C–Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice
bit.ly/4491HQp #OpenAccess
bit.ly/4491HQp #OpenAccess
Reposted by Teemu Strengell
New APA delirium guideline says NO to antipsychotics unless severe danger/distress. They failed in large trials:
www.psychiatry.org/getmedia/51e...
Use non-pharm approaches (and address underlying cause) in all patients, such as table 9:
pmc.ncbi.nlm.nih.gov/articles/PMC...
www.psychiatry.org/getmedia/51e...
Use non-pharm approaches (and address underlying cause) in all patients, such as table 9:
pmc.ncbi.nlm.nih.gov/articles/PMC...
September 5, 2025 at 12:01 PM
New APA delirium guideline says NO to antipsychotics unless severe danger/distress. They failed in large trials:
www.psychiatry.org/getmedia/51e...
Use non-pharm approaches (and address underlying cause) in all patients, such as table 9:
pmc.ncbi.nlm.nih.gov/articles/PMC...
www.psychiatry.org/getmedia/51e...
Use non-pharm approaches (and address underlying cause) in all patients, such as table 9:
pmc.ncbi.nlm.nih.gov/articles/PMC...
Reposted by Teemu Strengell
New 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults is here — developed with and endorsed by 12 leading organizations.
🫀 ow.ly/unFV50WGQFA
#CardioSky #MedSky @ajpcardio.bsky.social
🫀 ow.ly/unFV50WGQFA
#CardioSky #MedSky @ajpcardio.bsky.social
August 15, 2025 at 8:56 PM
New 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults is here — developed with and endorsed by 12 leading organizations.
🫀 ow.ly/unFV50WGQFA
#CardioSky #MedSky @ajpcardio.bsky.social
🫀 ow.ly/unFV50WGQFA
#CardioSky #MedSky @ajpcardio.bsky.social
Reposted by Teemu Strengell
Fingerstick blood glucose has comparatively poor sensitivity, with approximately 4 out of every 5 hypoglycemic events missed among nursing home residents. #geriatrics agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
August 16, 2025 at 7:29 PM
Fingerstick blood glucose has comparatively poor sensitivity, with approximately 4 out of every 5 hypoglycemic events missed among nursing home residents. #geriatrics agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
Reposted by Teemu Strengell
Comparison of plasma p‐tau217/Aβ42, p‐tau217, and Aβ42/Aβ40 biomarkers by race to detect Alzheimer's disease alz-journals.onlinelibrary.wiley.com/doi/10.1002/...
Comparison of plasma p‐tau217/Aβ42, p‐tau217, and Aβ42/Aβ40 biomarkers by race to detect Alzheimer's disease
INTRODUCTION
In clinically and racially diverse training and test sets, we evaluated and validated Alzheimer's disease (AD) plasma biomarkers: phosphorylated tau-217 (p-tau217), amyloid beta 1-42/1-.....
alz-journals.onlinelibrary.wiley.com
August 15, 2025 at 2:12 PM
Comparison of plasma p‐tau217/Aβ42, p‐tau217, and Aβ42/Aβ40 biomarkers by race to detect Alzheimer's disease alz-journals.onlinelibrary.wiley.com/doi/10.1002/...
Reposted by Teemu Strengell
⭐️ 📄 ⭐️
Recently @pharmermeg.bsky.social updated this open-access post. Originally published in 2017, the new version has a complete overhaul & provides a downloadable document. This is an article that has been read by by tens thousands of people 🌎🌍🌏.
www.idstewardship.com/cross-reacti... #IDsky
Recently @pharmermeg.bsky.social updated this open-access post. Originally published in 2017, the new version has a complete overhaul & provides a downloadable document. This is an article that has been read by by tens thousands of people 🌎🌍🌏.
www.idstewardship.com/cross-reacti... #IDsky
August 8, 2025 at 9:48 PM
⭐️ 📄 ⭐️
Recently @pharmermeg.bsky.social updated this open-access post. Originally published in 2017, the new version has a complete overhaul & provides a downloadable document. This is an article that has been read by by tens thousands of people 🌎🌍🌏.
www.idstewardship.com/cross-reacti... #IDsky
Recently @pharmermeg.bsky.social updated this open-access post. Originally published in 2017, the new version has a complete overhaul & provides a downloadable document. This is an article that has been read by by tens thousands of people 🌎🌍🌏.
www.idstewardship.com/cross-reacti... #IDsky
Reposted by Teemu Strengell
Blood Biomarkers: Testing for Alzheimer’s Disease
Professor Jonathan Schott @jmschott.bsky.social (UCL) explains how blood tests are reshaping Alzheimer’s diagnosis. Clear, current and clinically relevant.
Recorded at the Wessex Dementia Research Conference
youtu.be/3fLl1Mzwbsk
Professor Jonathan Schott @jmschott.bsky.social (UCL) explains how blood tests are reshaping Alzheimer’s diagnosis. Clear, current and clinically relevant.
Recorded at the Wessex Dementia Research Conference
youtu.be/3fLl1Mzwbsk
Blood Biomarkers & Testing for Alzheimer’s Disease
YouTube video by Dementia Researcher
youtu.be
August 4, 2025 at 12:37 PM
Blood Biomarkers: Testing for Alzheimer’s Disease
Professor Jonathan Schott @jmschott.bsky.social (UCL) explains how blood tests are reshaping Alzheimer’s diagnosis. Clear, current and clinically relevant.
Recorded at the Wessex Dementia Research Conference
youtu.be/3fLl1Mzwbsk
Professor Jonathan Schott @jmschott.bsky.social (UCL) explains how blood tests are reshaping Alzheimer’s diagnosis. Clear, current and clinically relevant.
Recorded at the Wessex Dementia Research Conference
youtu.be/3fLl1Mzwbsk
Reposted by Teemu Strengell
June 20, 2025 at 6:39 PM
Reposted by Teemu Strengell
🔥🔥Just published 🔥🔥
ATS CAP guidelines 2025
Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline
Free access pdf #IDsky#EMIMCC
www.atsjournals.org/doi/10.1164/...
ATS CAP guidelines 2025
Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline
Free access pdf #IDsky#EMIMCC
www.atsjournals.org/doi/10.1164/...
Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline | American Journal of Respiratory and Critical Care Medicine | Articles in P...
www.atsjournals.org
July 20, 2025 at 6:45 AM
🔥🔥Just published 🔥🔥
ATS CAP guidelines 2025
Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline
Free access pdf #IDsky#EMIMCC
www.atsjournals.org/doi/10.1164/...
ATS CAP guidelines 2025
Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline
Free access pdf #IDsky#EMIMCC
www.atsjournals.org/doi/10.1164/...
Reposted by Teemu Strengell
Woodworth et al. find that while LATE is the strongest predictor of hippocampal sclerosis of aging, vascular pathology is also independently associated—even after accounting for LATE. tinyurl.com/4m3zhjtn
May 8, 2025 at 9:50 AM
Woodworth et al. find that while LATE is the strongest predictor of hippocampal sclerosis of aging, vascular pathology is also independently associated—even after accounting for LATE. tinyurl.com/4m3zhjtn
Reposted by Teemu Strengell
Webinar now available online "Lewy Body Dementia: Future Directions" by Carla Abdelnour, MD @stanfordneuro.bsky.social @brainsupportnet.bsky.social rtnet.bsky.social @carlaabdelnour.bsky.social y.social
www.brainsupportnetwork.org/lbd-future-d...
www.brainsupportnetwork.org/lbd-future-d...
"Lewy Body Dementia: Future Directions" Webinar - Recording, Slides, and Resources - Brain Support Network
Brain Support Network and Stanford's Movement Disorders Center are pleased to present Carla Abdelnour, MD, were pleased to present Stanford's Carla Abdelnour, MD, speaking on
www.brainsupportnetwork.org
April 28, 2025 at 3:41 PM
Webinar now available online "Lewy Body Dementia: Future Directions" by Carla Abdelnour, MD @stanfordneuro.bsky.social @brainsupportnet.bsky.social rtnet.bsky.social @carlaabdelnour.bsky.social y.social
www.brainsupportnetwork.org/lbd-future-d...
www.brainsupportnetwork.org/lbd-future-d...
Reposted by Teemu Strengell
Managing Hypercholesterolemia in Adults Older Than 75 years Without a History of Atherosclerotic Cardiovascular Disease: An Expert Clinical Consensus From the National Lipid Association and AGS. #geriatrics #medsky agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
April 24, 2025 at 9:16 PM
Managing Hypercholesterolemia in Adults Older Than 75 years Without a History of Atherosclerotic Cardiovascular Disease: An Expert Clinical Consensus From the National Lipid Association and AGS. #geriatrics #medsky agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
Reposted by Teemu Strengell
I'm presenting today on High Dose #Psychiatry at the International Congress on Psychopharmcology in Turkey 4:30pm.
Hope to meet you if you're at the conference. Slides to the talk, which lays out what happens when we raise dose for various meds, here:
www.chrisaikenmd.com/highdosepsyc...
#pmhnp
Hope to meet you if you're at the conference. Slides to the talk, which lays out what happens when we raise dose for various meds, here:
www.chrisaikenmd.com/highdosepsyc...
#pmhnp
April 24, 2025 at 8:09 AM
I'm presenting today on High Dose #Psychiatry at the International Congress on Psychopharmcology in Turkey 4:30pm.
Hope to meet you if you're at the conference. Slides to the talk, which lays out what happens when we raise dose for various meds, here:
www.chrisaikenmd.com/highdosepsyc...
#pmhnp
Hope to meet you if you're at the conference. Slides to the talk, which lays out what happens when we raise dose for various meds, here:
www.chrisaikenmd.com/highdosepsyc...
#pmhnp
Reposted by Teemu Strengell
Eve Marder has a nice commentary on our paper out in the Journal of General Physiology:
"What happened to the pursuit of truth?"
doi.org/10.1085/jgp....
"What happened to the pursuit of truth?"
doi.org/10.1085/jgp....
What happened to the pursuit of truth? | Journal of General Physiology | Rockefeller University Press
The knowledge in our brains, not in our phones, is necessary for creative thinking and the pursuit of truth.
doi.org
October 24, 2024 at 12:19 PM
Eve Marder has a nice commentary on our paper out in the Journal of General Physiology:
"What happened to the pursuit of truth?"
doi.org/10.1085/jgp....
"What happened to the pursuit of truth?"
doi.org/10.1085/jgp....
Reposted by Teemu Strengell
Recently saw anticholinergic toxicity in the ED. Physostigmine wasn’t available, so we used rivastigmine (6 mg caps & 13.3 mg patches) to reverse anticholinergic delirium/toxidrome—and it worked! #medsky #EMSky #Pharmsky #SkyRx
pmc.ncbi.nlm.nih.gov/articles/PMC...
pubmed.ncbi.nlm.nih.gov/38465631/
pmc.ncbi.nlm.nih.gov/articles/PMC...
pubmed.ncbi.nlm.nih.gov/38465631/
Rivastigmine Use in the Treatment of Antimuscarinic Delirium
pmc.ncbi.nlm.nih.gov
November 13, 2024 at 12:27 AM
Recently saw anticholinergic toxicity in the ED. Physostigmine wasn’t available, so we used rivastigmine (6 mg caps & 13.3 mg patches) to reverse anticholinergic delirium/toxidrome—and it worked! #medsky #EMSky #Pharmsky #SkyRx
pmc.ncbi.nlm.nih.gov/articles/PMC...
pubmed.ncbi.nlm.nih.gov/38465631/
pmc.ncbi.nlm.nih.gov/articles/PMC...
pubmed.ncbi.nlm.nih.gov/38465631/
Reposted by Teemu Strengell
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials 🔭🧑🔬🥼 #Diabetes #NephSky #CardioSky #Cardiovascular #Cardiovasculardisease #KidneyDisease #Type2Diabetes 👇👇
www.thelancet.com/journals/lan...
www.thelancet.com/journals/lan...
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
We found evidence that GLP-1 receptor agonists significantly reduce clinically important
kidney events, kidney failure, and cardiovascular events.
www.thelancet.com
November 29, 2024 at 11:48 AM
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials 🔭🧑🔬🥼 #Diabetes #NephSky #CardioSky #Cardiovascular #Cardiovasculardisease #KidneyDisease #Type2Diabetes 👇👇
www.thelancet.com/journals/lan...
www.thelancet.com/journals/lan...